Company intelligence / Profile preview

Complement Genomics

Lanchester, Co. Durham, UKcompgeno.com ↗

Ownership: Private
Employees: ~15
Development stage: Commercial

Overview

Complement Genomics is an established UK-based DNA testing and molecular analysis company offering accredited genomic services for human identity, clinical trials support, animal/plant identification, pharmacogenetics, and COVID‑19 diagnostics. It operates ISO/IEC 17025 accredited laboratories recognized by the UK Ministry of Justice. The company has contributed to public health efforts during the COVID‑19 pandemic with rapid PCR-based SARS-CoV‑2 testing.

Therapeutic areas: OtherInfectious Diseases
Modalities: PCR-based diagnosticsNext generation sequencingDigital PCR
Industry: Molecular Diagnostics

Partnerships

Expression Analysis (partnership for molecular/bioanalytical services)Various legal/social service organizations for paternity/human relationship DNA testsNHS/local healthcare providers during COVID‑19 response

Beyond the preview

Go deeper on Complement Genomics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Complement Genomics.

Explore the full profile